Long-term senolytic therapy with Dasatinib and Quercetin alleviates lipofuscin-dependent retinal degeneration in mice.

Yang B, Yang K, Xi R, Li S, Chen J, Wu Y.

Open source

DOI
10.1016/j.redox.2025.103716
Published
2025-06-06
Container
Redox Biol
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.redox.2025.103716,
  title = {Long-term senolytic therapy with Dasatinib and Quercetin alleviates lipofuscin-dependent retinal degeneration in mice.},
  author = {Yang B and  Yang K and  Xi R and  Li S and  Chen J and  Wu Y.},
  year = {2025},
  journal = {Redox Biol},
  doi = {10.1016/j.redox.2025.103716},
  url = {https://doi.org/10.1016/j.redox.2025.103716}
}

RIS

TY  - JOUR
TI  - Long-term senolytic therapy with Dasatinib and Quercetin alleviates lipofuscin-dependent retinal degeneration in mice.
AU  - Yang B
AU  -  Yang K
AU  -  Xi R
AU  -  Li S
AU  -  Chen J
AU  -  Wu Y.
PY  - 2025
JO  - Redox Biol
DO  - 10.1016/j.redox.2025.103716
UR  - https://doi.org/10.1016/j.redox.2025.103716
ER  - 

APA

B, Y., K, Y., R, X., S, L., J, C., & Y., W. (2025). Long-term senolytic therapy with Dasatinib and Quercetin alleviates lipofuscin-dependent retinal degeneration in mice.. Redox Biol. https://doi.org/10.1016/j.redox.2025.103716

Source records